SKI Market

A+| A| A-|

Indian Indices

Sensex

71,947.55 -1,635.67
( -2.22%)

Global Indices

Nasdaq

45,242.12 54.47
(0.12%)

Dow Jones

6,365.58 -24.27
(-0.38%)

Hang Seng

51,264.29 -621.56
(-1.20%)

Nikkei 225

10,176.45 48.49
(0.48%)

Forex

USD-INR

94.53 0.44
(0.47%)

EUR-INR

108.77 0.13
(0.12%)

GBP-INR

125.32 -0.25
(-0.20%)

JPY-INR

0.59 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Accelya Solutions India Ltd

Industry : Computers - Software - Medium / Small

BSE Code

ISIN Demat

Book Value()

532268

INE793A01012

160.722408

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ACCELYA

13.32

1530.24

EPS(TTM)

Face Value()

Div & Yield %

76.99

8.78

Back

Strides Pharma Science consolidated net profit rises 129.80% in the December 2025 quarter

Jan 30,2026

Net profit of Strides Pharma Science rose 129.80% to Rs 202.11 crore in the quarter ended December 2025 as against Rs 87.95 crore during the previous quarter ended December 2024. Sales rose 3.55% to Rs 1194.65 crore in the quarter ended December 2025 as against Rs 1153.67 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1194.65	1153.67	4
OPM %	19.75	18.23	-
PBDT	299.40	164.70	82
PBT	248.78	116.28	114
NP	202.11	87.95	130

71,947.55 -1,635.67 ( -2.22%)

45,242.12 54.47 (0.12%)

6,365.58 -24.27 (-0.38%)

51,264.29 -621.56 (-1.20%)

10,176.45 48.49 (0.48%)

94.53 0.44 (0.47%)

108.77 0.13 (0.12%)

125.32 -0.25 (-0.20%)

0.59 0.00 (-0.02%)